Stock Report

Download full stock data and analysis for free Last Updated: 21-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Amneal Pharmaceuticals Inc Class A (AMRX) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$20.24

up-down-arrow $8.06 (66.17%)

As on 21-Oct-2026 10:45EDT

Market cap

info icon

$6,680 Mln

Revenue (TTM)

info icon

$3,118 Mln

P/E Ratio

info icon

39.1

P/B Ratio

info icon

204

Div. Yield

info icon

0 %

Edit peer-selector-edit
Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Market cap ($ Mln)
 6,680 11,908 12,979 11,757 8,801
Revenue ($ Mln)
 3,118 831 713 5,020 432
Net Profit ($ Mln)
 157.36 54.90 -696.24 -199.00 -136.72
Net Margin (%)
 5.05 6.61 -97.64 -3.96 -31.66
RoE (%)
 -- 8.11 -- -3.03 -30.32
Price to Earnings
 39.14 244.80 -- -- --
Price-To-Book
 203.97 18.00 123.68 1.71 23.58

Income Statement ($ Mln)

Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Operating Revenue arrow
3,117.55 830.81 713.07 5,020.00 431.80
Cost of Revenue arrow
1,891.76 14.09 47.45 2,380.00 207.41
Gross Profit arrow
1,136.09 748.43 473.81 2,050.00 191.00
Operating Expenses arrow
822.55 810.32 1,209.09 2,178.00 362.16
Operating Profit (EBIT) arrow
403.24 6.41 -543.47 462.00 -137.77
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
201.18 26.37 -706.17 -166.00 -135.85
Provision for Tax arrow
-14.14 -35.26 -7.73 33.00 0.24
Profit after Tax (Net Income) arrow
157.36 54.90 -696.24 -199.00 -136.72
Minority Interest arrow
-57.96 0.00 10.15 0.00 0.00
Consolidated Profit arrow
0.00 0.00 0.00 0.00 0.00

Liabilities ($ Mln)

Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Shareholder's Funds arrow
33.02 705.78 -2,515.22 6,588.00 445.74
Minority Interest arrow
-57.96 0.00 10.15 0.00 0.00
Non-Current Liabilities arrow
2,776.18 29.12 2,832.54 5,121.00 106.44
Current Liabilities arrow
883.19 153.80 890.65 1,852.00 120.26
Total Liabilities arrow
3,678.28 836.65 936.03 13,358.00 641.86

Assets ($ Mln)

Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Non-Current Assets arrow
1,829.32 449.03 124.16 9,764.00 351.14
Current Assets arrow
1,947.03 439.68 1,093.14 3,797.00 321.30
Total Assets arrow
3,678.28 836.65 936.03 13,358.00 641.86
Total Debt* arrow
2,791.76 9.42 2,493.78 3,918.00 93.59
Net Current Assets arrow
1,063.84 285.87 202.49 1,945.00 201.04

Cashflow ($ Mln)

Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Cash From Operating Activities arrow
339.99 142.00 -445.91 560.00 -47.63
Cash Flow from Investing Activities arrow
-112.26 69.76 -24.49 -279.00 -24.76
Cash from Financing Activities arrow
-31.53 -220.37 359.29 -275.00 28.54
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
ROCE (%) arrow
2.80 14.87 -159.44 -2.21 -13.30
ROE (%) arrow
-80.04 8.11 41.15 -3.03 -30.32
ROA (%) arrow
3.42 5.52 -41.39 -1.30 -17.95
EBIT Margin (%) arrow
14.69 3.17 -86.43 1.61 -30.84
Net Margin (%) arrow
5.05 6.61 -97.64 -3.96 -31.66
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Revenue Growth (%) arrow
9.28 16.02 202.39 11.95 19.19
EBIT Growth (%) arrow
35.27 -79.11 5.05 -90.61 -57.38
Net Profit Growth (%) arrow
4,562.61 -58.66 10.33 -145.85 -60.49
EPS Growth (%) arrow
7,441.17 -62.44 12.58 -146.42 -52.59
Book Value Growth (%) arrow
128.83 12.98 -36.90 -3.87 -8.64

Valuation Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Price / Earnings arrow
56.80 41.86 -20.69 -48.47 -21.89
Price / Book Value arrow
-57.81 6.44 -7.27 1.72 3.60
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
10.79 55.67 -25.47 21.77 -30.81
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Debt to Equity arrow
77.65 0.00 -0.77 0.58 0.00
Short term debt to equity ratio arrow
3.68 0.00 -0.22 0.01 0.02
Current Ratio arrow
2.20 2.86 1.23 2.05 2.67
Quick Ratio arrow
1.44 2.77 1.17 1.10 2.38
Interest Coverage arrow
1.88 -- -6.86 0.36 --

Operating Efficiency Ratios

 Amneal Pharmaceuticals Inc Class A (AMRX) Corcept Therapeutics (CORT) BridgeBio Pharma (BBIO) Elanco Animal Health (ELAN) Twist Bioscience Corp (TWST)
Debtors to sales (%) arrow
32.74 9.26 35.69 22.95 15.23
Asset Turnover arrow
0.68 0.84 0.42 0.33 0.57
Receivable days arrow
103.79 28.27 52.44 70.73 44.72
Inventory Days arrow
118.22 355.76 172.81 226.89 51.56
Payable days arrow
49.91 785.55 296.14 45.50 12.52
Cash Conversion Cycle arrow
172.10 -401.52 -70.89 252.12 83.76
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...